Logo Logo
Group by: Item Type | Date
Jump to: 2021 | 2020 | 2017
Number of items: 3.

2021

Venet, David; Rediti, Mattia; Maetens, Marion; Fumagalli, Debora; Brown, David N.; Majjaj, Samira; Salgado, Roberto; Pusztai, Lajos; Harbeck, Nadia; El-Abed, Sarra; Wang, Yingbo; Saura, Cristina; Gomez, Henry; Semiglazov, Vladimir Fedorovich; de Azambuja, Evandro; Huober, Jens; Nuciforo, Paolo; Di Cosimo, Serena; Piccart, Martine; Loi, Sherene; Rothe, Francoise and Sotiriou, Christos (2021): Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial. In: Clinical Cancer Research, Vol. 27, No. 20: pp. 5607-5618

2020

Gonzalez-Ericsson, Paula I.; Stovgaard, Elisabeth S.; Sua, Luz F.; Reisenbichler, Emily; Kos, Zuzana; Carter, Jodi M.; Michiels, Stefan; Le Quesne, John; Nielsen, Torsten O.; Laenkholm, Anne-Vibeke; Fox, Stephen B.; Adam, Julien; Bartlett, John M. S.; Rimm, David L.; Quinn, Cecily; Peeters, Dieter; Dieci, Maria V.; Vincent-Salomon, Anne; Cree, Ian; Hida, Akira I.; Balko, Justin M.; Haynes, Harry R.; Frahm, Isabel; Acosta-Haab, Gabriela; Balancin, Marcelo; Bellolio, Enrique; Yang, Wentao; Kirtani, Pawan; Sugie, Tomoharu; Ehinger, Anna; Castaneda, Carlos A.; Kok, Marleen; McArthur, Heather; Siziopikou, Kalliopi; Badve, Sunil; Fineberg, Susan; Gown, Allen; Viale, Giuseppe; Schnitt, Stuart J.; Pruneri, Giancarlo; Penault-Llorca, Frederique; Hewitt, Stephen; Thompson, E. Aubrey; Allison, Kimberly H.; Symmans, William F.; Bellizzi, Andrew M.; Brogi, Edi; Moore, David A.; Larsimont, Denis; Dillon, Deborah A.; Lazar, Alexander; Lien, Huangchun; Goetz, Matthew P.; Broeckx, Glenn; El Bairi, Khalid; Harbeck, Nadia; Cimino-Mathews, Ashley; Sotiriou, Christos; Adams, Sylvia; Liu, Shi-Wei; Loibl, Sibylle; Chen, I-Chun; Lakhani, Sunil R.; Juco, Jonathan W.; Denkert, Carsten; Blackley, Elizabeth F.; Demaria, Sandra; Leon-Ferre, Roberto; Gluz, Oleg; Zardavas, Dimitrios; Emancipator, Kenneth; Ely, Scott; Loi, Sherene; Salgado, Roberto and Sanders, Melinda (2020): The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. In: Journal of Pathology, Vol. 250, No. 5: pp. 667-684

2017

Fumagalli, Debora; Venet, David; Ignatiadis, Michail; Azim, Hatem A.; Maetens, Marion; Rothé, Francoise; Salgado, Roberto; Bradbury, Ian; Pusztai, Lajos; Harbeck, Nadia; Gomez, Henry; Chang, Tsai-Wang; Coccia-Portugal, Maria Antonia; Cosimo, Serena di; Azambuja, Evandro de; Peña, Lorena de la; Nuciforo, Paolo; Brase, Jan C.; Huober, Jens; Baselga, José; Piccart, Martine; Loi, Sherene and Sotiriou, Christos (2017): RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy A Secondary Analysis of the NeoALTTO Randomized Clinical Trial. In: Jama Oncology, Vol. 3, No. 2: pp. 227-234

This list was generated on Sun Feb 18 05:19:24 2024 CET.